Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
PharmAbcine Presents Updated Preclinical Data of Its Anti-VISTA Antibody Candidate at AACR 2022 2022-04-11 20:00
InventisBio Reported Promising Phase I Study Results of a Novel KRAS G12C Inhibitor D-1553 in Cancer Patients 2022-04-11 17:37
Gracell Biotechnologies to Present Data at AACR Annual Meeting 2022 Showcasing Early First-in-Human Results for GC502 in r/r B-ALL 2022-04-09 04:00
KAZIA THERAPEUTICS ANNOUNCES PRECLINICAL DATA PRESENTED AT AACR CONFERENCE BY JOHNS HOPKINS UNIVERSITY SHOWING ACTIVITY OF PAXALISIB IN PAEDIATRIC BRAIN TUMOURS 2022-04-08 20:30
TWO ABSTRACTS AT AACR CONFERENCE PRESENT DETAILED STUDY DESIGN AND INNOVATIVE BIOMARKER STRATEGY FOR ONGOING PHASE I STUDY OF EVT801 IN ADVANCED CANCER 2022-04-08 20:00
OliX Pharmaceuticals Identifies Inhibition of Target Gene Expression in Nonhuman Primate Models for NASH Candidate 2022-04-08 20:00
AGC to Expand Synthetic Pharmaceutical Production Base in Spain 2022-04-08 14:00
WuXi AppTec Recognized as Top-Rated ESG Company by Sustainalytics 2022-04-08 08:00
CARsgen Appoints Dr. Raffaele Baffa as Chief Medical Officer 2022-04-07 23:42
SeekIn Receives CE Mark Approval for LeukoPrint® Molecular Karyotyping Test 2022-04-07 22:22
REDCLOUD BIO TO PRESENT PRECLINICAL DATA OF NEXT-GENERATION EGFR TKI H002 AT ANNUAL MEETING OF AMERICAN ASSOCIATION OF CANCER RESEARCH 2022-04-07 19:47
Psychobiotic PS128 Registration, Health Claims Approved in Thailand, Canada 2022-04-07 11:20
Alterity Therapeutics Announces Presentation of bioMUSE Data at the American Academy of Neurology (AAN) Annual Meeting 2022-04-07 09:34
Harbour BioMed Announces Global Out-License Agreement with AstraZeneca for CLDN18.2xCD3 Bispecific Antibody HBM7022 2022-04-07 09:09
ENSEM Therapeutics, a CBC Group-Incubated Biopharma Company, Raises $67 Million in Series A Financing to Develop Small Molecule Medicines for Difficult-to-Drug Targets 2022-04-07 04:00
HitGen and UPPTHERA Extend PROTAC Research Collaboration after Hit Finding Success on Undruggable Targets 2022-04-06 22:30
New Studies at AACR 2022 Highlight Lunit SCOPE's Immune Phenotyping Capabilities 2022-04-06 21:44
Pregene Enters into Innovative Partnership with CellPoint to Develop anti-BCMA CAR-T Cell Therapy in Europe and the US 2022-04-06 20:30
Volition appoints Sharon Ballesteros as U.S. Head of Quality and Development Process 2022-04-06 20:00
Harbour BioMed Announces Poster Presentation on the Novel Bispecific Antibody PD-L1xCD40 at Upcoming American Association for Cancer Research (AACR) Annual Meeting 2022-04-06 15:04
1 132 133 134 135 136 432